相关实验视频
Updated: Jul 17, 2026

09:30
Modeling Ligands into Maps Derived from Electron Cryomicroscopy
Published on: July 19, 2024
在分子动力学模拟中观察到的刚果红色到粉样蛋白原纤维表面的双结合模式
Chun Wu1, Zhixiang Wang, Hongxing Lei
1UC Davis Genome Center and Department of Applied Science, University of California, Davis, California 95616, USA.
Journal of the American Chemical Society
|February 1, 2007
概括
刚果红色以两种特定方式结合粉样纤维,为其抑制机制提供了洞察力. 这一发现可能会导致针对粉样蛋白疾病的新型非类药物.
科学领域:
- 生物物理学的生物物理.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 刚果红色是组织中粉样纤维的长期存在的染色.
- 它对粉样β纤维素形成和毒性表现出弱抑制作用.
- 刚果红的确切的结合特异性和抑制机制尚未完全理解.
研究的目的:
- 描述刚果红色到粉样原纤维的特定结合方式.
- 阐明刚果红的抑制作用背后的分子机制.
- 探索开发新的粉样蛋白特异性抑制剂的潜力.
主要方法:
- 使用显式溶剂模型进行全原子分子动力学模拟.
- 模拟集中在由酵母蛋白Sup35片段 (GNNQQNY) 形成的原纤维上.
- 分子力学概括的诞生表面积 (MM-GBSA) 用于结合能量的估计.
主要成果:
- 确定了刚果红色与GNNQQNY原纤维素的两个不同的结合模式.
- 主要结合模式,涉及沿着β-sheet延伸的槽,比二次模式更稳定 (-5.7 kcal/mol).
- 发现疏水性相互作用对于刚果红的结合亲和力至关重要.
结论:
- 鉴定到的结合方式,特别是主要的结合方式,表明粉样纤维素的一般识别机制是由刚果红色和类似的分子.
- 主结合模式提供了破坏β-sheet堆叠的潜在机制.
- 这些发现为设计针对粉样蛋白相关疾病的新型非基抑制剂铺平了道路.
更多相关视频
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
10:19Single-Molecule FRET Imaging for Observing the Conformational Dynamics of Dynamin-Like GTPase Atlastin
Published on: January 24, 2025
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Globular and Fibrous Proteins
Many proteins can be classified into two distinct subtypes - globular or fibrous. These two types differ in their shapes and solubilities.
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...